Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 2, 2010, Pages 362-367

  Yoshikawa, Eiji ^a   Marui, Akira ^a   Tsukashita, Masaki ^a   Nishina, Takeshi ^a   Wang, Jian ^a   Muranaka, Hiroyuki ^a   Ikeda, Tadashi ^a   Komeda, Masashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Heart failure; Ischaemic heart disease; Surgical ventricular restoration

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIASTOLIC DYSFUNCTION; DRUG MEGADOSE; DRUG POTENCY; GENE EXPRESSION; HEART LEFT VENTRICLE ANEURYSM; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEART VENTRICLE REMODELING; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURGICAL VENTRICULAR RESTORATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARBAZOLES; DRUG EVALUATION, PRECLINICAL; FIBROSIS; GENE EXPRESSION REGULATION; HEART CATHETERIZATION; HEART VENTRICLES; HEMODYNAMICS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; ORGAN SIZE; POSTOPERATIVE CARE; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR REMODELING;

EID: 74149087856     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.04.072     Document Type: Article

References (28)

1. Komeda M., David T.E., Malik A., Ivanov J., and Sun Z. Operative risk and long-term results of operation for left ventricular aneurysm. Ann Thorac Surg 53 (1992) 22-29
2. Dor V., Sabatier M., Di Donato M., Montiglio F., Toso A., and Maioli M. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 116 (1998) 50-59
3. Nishina T., Nishimura K., Yuasa S., Miwa S., Nomoto T., Sakakibara Y., Handa N., Hamanaka I., Saito Y., and Komeda M. Initial effects of the left ventricular repair by plication may not last long in a rat ischemic cardiomyopathy model. Circulation 104 Suppl. I (2001) I241-I245
4. Nomoto T., Nishina T., Miwa S., Tsuneyoshi H., Maruyama I., Nishimura K., and Komeda M. Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats. Circulation 106 Suppl. I (2002) I115-I119
5. Tsuneyoshi H., Nishina T., Nomoto T., Kanemitsu H., Kawakami R., Unimonh O., Nishimura K., and Komeda M. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair. Circulation 110 Suppl. II (2004) II174-II179
6. Kanemitsu H., Takai S., Tsuneyoshi H., Yoshikawa E., Nishina T., Miyazaki M., Ikeda T., and Komeda M. Chronic chymase inhibition preserves cardiac function after left ventricular repair in rats. Eur J Cardiothorac Surg 33 (2008) 25-31
7. Tsukashita M., Marui A., Nishina T., Yoshikawa E., Kanemitsu H., Wang J., Ikeda T., and Komeda M. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery. J Thorac Cardiovasc Surg 136 (2008) 58-64
8. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., Tavazzi L., Smiseth O.A., Gavazzi A., Haverich A., Hoes A., Jaarsma T., Korewicki J., Lévy S., Linde C., Lopez-Sendon J.L., Nieminen M.S., Piérard L., Remme W.J., and Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 11 (2005) 1115-1140
9. Feuerstein G.Z., Bril A., and Ruffolo Jr. R.R. Protective effects of carvedilol in the myocardium. Am J Cardiol 80 (1997) 41-45
10. Sung C.P., Arleth A.J., and Ohlstein E.H. Carvedilol inhibits vascular smooth muscle cell proliferation. J Cardiovasc Pharmacol 21 (1993) 221-227
11. Australia/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997;349:375-80.
12. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., and Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
13. Tsuneyoshi H., Oriyanhan W., Kanemitsu H., Shiina R., Nishina T., Ikeda T., and Komeda M. Heterotopic transplantation of the failing rat heart as a model of left ventricular mechanical unloading toward recovery. ASAIO J 51 1 (2005) 116-120
14. Alderman E.L., Bourassa M.G., Cohen L.S., Davis K.B., Kaiser G.G., Killip T., Mock M.B., Pettinger M., and Robertson T.L. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 82 (1990) 1629-1646
15. Cleland J.G., Freemantle N., Ball S.G., Bonser R.S., Camici P., Chattopadhyay S., Dutka D., Eastaugh J., Hampton J., Large S., Norell M.S., Pennell D.J., Pepper J., Sanda S., Senior R., and Smith D. The heart failure revascularisation trial (HEART): rationale, design and methodology. Eur J Heart Fail 5 (2003) 295-303
16. Wei S., Chow L.T., and Sanderson J.E. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. J Am Coll Cardiol 36 (2000) 276-281
17. Yaoita H., Sakabe A., Maehara K., and Maruyama Y. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Circulation 105 (2002) 975-980
18. Poole-Wilson P.A., Swedberg K., Cleland J.G., Di Lenarda A., Hanrath P., Komajda M., Lubsen J., Lutiger B., Metra M., Remme W.J., Torp-Pedersen C., Scherhag A., Skene A., and Carvedilol or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362 (2003) 7-13
19. Di Donato M., Sabatier M., Toso A., Barletta G., Baroni M., Dor V., and Fantini F. Regional myocardial performance of non-ischaemic zones remote from anterior wall left ventricular aneurysm. Effects of aneurysmectomy. Eur Heart J 16 (1995) 1285-1292
20. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., and Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44 (1979) 503-512
21. Sutton M.G., and Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101 (2000) 2981-2988
22. Li B., Liao Y.H., Cheng X., Ge H., Guo H., and Wang M. Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction. Int J Cardiol 111 (2006) 247-255
23. Sun Y.L., Hu S.J., Wang L.H., Hu Y., and Zhou J.Y. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats. Chest 128 (2005) 1812-1821
24. Sia Y.T., Parker T.G., Tsoporis J.N., Liu P., Adam A., and Rouleau J.L. Long-term effects of carvedilol on left ventricular function, remodeling, and expression of cardiac cytokines after large myocardial infarction in the rat. J Cardiovasc Pharmacol 39 (2002) 73-87
25. Yang Y., Tang Y., Ruan Y., Wang Y., Gao R., Chen J., and Chen Z. Comparison of metoprolol with low, middle and high doses of carvedilol in prevention of postinfarction left ventricular remodeling in rats. Jpn Heart J 44 (2003) 979-988
26. Sun Y., Zhang J.Q., Zhang J., and Lamparter S. Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med 135 (2000) 316-323
27. Salati M., Paje A., Di Biasi P., Fundaro P., Cialfi A., and Santoli C. Severe diastolic dysfunction after endoventriculoplasty. J Thorac Cardiovasc Surg 109 (1995) 694-701
28. Prabhu S.D., Chandrasekar B., Murray D.R., and Freeman G.L. beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 101 (2000) 2103-2109